Polaryx Therapeutics PLYX Ratios (2025-2026)

NASDAQ PLYX
$2.02 -0.05 (-2.42%)
At close: Oct 1, 2026 · 4:00 PM EDT
Reported Financials

Polaryx Therapeutics Quarterly Ratios

Periods 5 quarters
Latest Jun 2026

Polaryx Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 5 quarters of results from Mar 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 4.34M7.66M
Equity AverageEquity Avg. 4.48M3.75M3.91M3.53M6.71M
Valuation
Price to BookP/B 143.8612.12
Enterprise Value 354.84M121.05M
Market Capitalization 357.92M132.59M
Return Ratios
Return on Capital Employed [ROCE]ROCE -136.70%
Return on Assets [ROA]ROA -121.12%
Return on Equity [ROE]ROE -138.14%

Polaryx Therapeutics Ratios API

Pull Polaryx Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PLYX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY